Arcutis Elevates Mas Matsuda to EVP and Chief Legal Officer Overseeing ZORYVE Growth
Arcutis Biotherapeutics promoted Mas Matsuda from senior vice president and general counsel to executive vice president, chief legal officer and corporate secretary to oversee legal, compliance, governance and intellectual property strategy. Matsuda’s role will support ZORYVE commercialization, six FDA approvals and corporate transactions during the company’s next phase of growth.
1. Promotion Details
Mas Matsuda moves from senior vice president and general counsel to executive vice president, chief legal officer and corporate secretary, reflecting his role in guiding the company’s legal and governance framework.
2. Leadership Responsibilities
He will oversee legal, compliance and governance strategy, protect intellectual property and manage corporate transactions as Arcutis advances its commercial-stage operations.
3. ZORYVE Franchise Support
Since joining in 2022, Matsuda has supported six FDA approvals of the ZORYVE portfolio and will continue to drive its market rollout.
4. Next Growth Phase
His promotion aligns with the company’s plan to expand commercial presence, develop its pipeline and sustain long-term growth.